Diffuse Large B-Cell Lymphoma in Chile: The Impact of Combined CHOP Plus Rituximab in the Public Health System

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. The purpose of this study was to evaluate the clinical features, prognostic factors, and results of DLBCL that was treated in the cancer centers of the public health system in Chile and compare cyclophosphamide, doxorubicin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabrera, María Elena, Peña, Camila, Leon, Pilar, Lois, Vivianne, Rojas, Hernán, Vega, Valeska, Pizarro, Alvaro, Calderon, Susana, Rojas, Christine, Aspillaga, Augusto, Gonzalez, M. Luisa, Intriago, Marvila, Rojas, Bernardita, Hales, Cecilia, Oliva, Jacqueline, Romero, Mónica, Capurro, Marisa, Castillo, Jorge J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166504/
https://www.ncbi.nlm.nih.gov/pubmed/36351213
http://dx.doi.org/10.1200/GO.22.00165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166504/
https://www.ncbi.nlm.nih.gov/pubmed/36351213
http://dx.doi.org/10.1200/GO.22.00165

Ejemplares similares